An expert panel developed practical recommendations for cardiovascular risk management in 8 high-risk pediatric diagnoses associated with very premature cardiovascular disease.
This scientific statement provides expert consensus recommendations for managing cardiovascular risk in pediatric patients with specific high-risk diagnoses prone to premature atherosclerosis.
Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.
Kavey et al. (Tue,) conducted a review in High-risk pediatric diagnoses with premature cardiovascular disease. Cardiovascular risk management was evaluated. An expert panel developed practical recommendations for cardiovascular risk management in 8 high-risk pediatric diagnoses associated with very premature cardiovascular disease.